🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 61225M102
- Market Cap
- Small Cap
- IPO
- 6/24/2021 · $19.00/share
Business: Monte Rosa Therapeutics is discovering and developing molecular glues to degrade disease-causing proteins. The company has created a platform to rationally design small molecules that reprogram ubiquitin ligases to eliminate disease drivers previously deemed undruggable.
Company Contact
- CEO
- Markus Warmuth
- CFO
- Ajim Tamboli
- Headquarters
- 645 Summer Street, Suite 102, Boston, MA 02210
- Phone
- 617-949-2643
- Investor Relations
- John Graziano, Solebury Trout · ir@monterosatx.com